Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-04-29

FDA Approved: NABUMETONE — Supplemental Application (Chartwell RX, LLC)

View source ↗

Summary

FDA approves a supplemental application for nabumetone submitted by Chartwell RX, LLC. Nabumetone is an NSAID used for pain relief in conditions like osteoarthr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nabumetone (Nabumetone)

Snippet

SUPPL AP for NABUMETONE (NABUMETONE)